1. Home
  2. OGI vs SGMT Comparison

OGI vs SGMT Comparison

Compare OGI & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

N/A

Current Price

$1.40

Market Cap

189.5M

Sector

Health Care

ML Signal

N/A

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

N/A

Current Price

$7.85

Market Cap

169.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
OGI
SGMT
Founded
2013
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.5M
169.4M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
OGI
SGMT
Price
$1.40
$7.85
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$26.13
AVG Volume (30 Days)
754.6K
2.5M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,000,000.00
Revenue This Year
$20.10
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
$13.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$3.15
52 Week High
$2.24
$11.41

Technical Indicators

Market Signals
Indicator
OGI
SGMT
Relative Strength Index (RSI) 49.60 63.68
Support Level $1.30 $6.61
Resistance Level $1.72 $9.11
Average True Range (ATR) 0.08 0.68
MACD -0.01 0.14
Stochastic Oscillator 22.22 61.26

Price Performance

Historical Comparison
OGI
SGMT

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: